Psychedelic Medicine for Addiction & Mental Health Recovery: Expert Panel Discussion скачать в хорошем качестве

Psychedelic Medicine for Addiction & Mental Health Recovery: Expert Panel Discussion

What we’ll cover: Join us to learn: breakthrough treatment approaches for substance use disorders and common co-occurring conditions. Psychedelic medicine research for mental health recovery is gaining traction and becoming legal in many states. Many controversies remain, most notably the use of psychedelics among those with a history of addictive disorders. The panel consists of addiction experts who have direct experience utilizing psychedelics among those with a wide range of psychiatric profiles. We will discuss indications, contraindications, blind spots, controversies, and best practices when considering psychedelic medicine for addiction recovery. This will be a historic evening that you won’t want to miss, filled with case studies, enlightening discussions, and expert insights on integrating psychedelics into addiction and mental health practices. Join us for a thought-provoking conversation about the next wave of mental health care. What is the Event? 150 mental health professionals are coming together for learning and networking in West LA. Hosted by Dr. David Wiss and a curated panel of expert mental health treatment pioneers. Who is it for? Mental health and addiction treatment providers who are looking to learn more about alternative treatment options and engage in community-building. Topics include: ketamine, psilocybin, MDMA, ayahuasca, ibogaine This event will be groundbreaking for clinicians working in substance use disorder and mental health treatment, including but not limited to: LMFT/AMFT LCSW/MSW PhD/PsyD (Psychologists) RDNs (Dietitians) MD Psychiatrist MD Addiction Medicine Psychiatric Nurse Practitioner Drug/Alcohol Counselor Treatment Owner/Operators Business Development Schedule: 5:00 pm Networking & Appetizers 6:00 pm Program Begins 8:00 pm Dinner & Networking Program: Moderator Dr. David Wiss will present complex clinical vignettes and solicit recommendations from a panel of treatment experts, with time reserved for audience questions and discussion. Panelists: Joyce Braverman, MD Dana Lerman, MD Kalen Flynn, MD Yeshaia Blakeney Marcos Mourkakos